Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial

Abstract Background Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is currently standard care after percutaneous coronary intervention (PCI) with stent insertion, and aims to inhibit platelet function in order to prevent stent thrombosis. The P2Y12 blocker ticagrelor (TIC) h...

Full description

Bibliographic Details
Main Authors: Sarah Baos, Wendy Underwood, Lucy Culliford, Barnaby C. Reeves, Chris A. Rogers, Ruth Bowles, Tom Johnson, Andreas Baumbach, Andrew Mumford
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Trials
Subjects:
Antiplatelet therapy
Platelet function
Haematology
Ticagrelor
Clopidogrel
Prasugrel
Online Access:http://link.springer.com/article/10.1186/s13063-017-2277-9

Internet

http://link.springer.com/article/10.1186/s13063-017-2277-9

Similar Items